Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.5% | -5.2% | -89% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 74.8% | 76.4% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -678.5% | -581.3% | -519.2% | 30% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -707.8% | -580.2% | -510.9% | 34.9% |
| EPS Diluted | -0.32 | -0.31 | -0.29 | 0.17 |
| % Growth | -3.2% | -6.9% | -270.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |